Company: ATRA
Filing Date: 2025-03-31
Form Type: 8-K
Source: 0001193125-25-068789
Chunk: 1

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-03-31
Form: 8-K
Item: Item 5.02
Chunk 1
---
 and any other persons pursuant to which Ms. Grant-Huerta was promoted to Chief Accounting Officer. There are no family relationships between Ms. Grant-Huerta and any director, executive officer or any other person nominated or chosen by the Company to become a director or executive officer. There are no related person transactions (within the meaning of Item 404(a) of Regulation S-Kpromulgated by the Securities and Exchange Commission) between Ms. Grant-Huerta and the Company.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                     ATARA BIOTHERAPEUTICS, INC.                                
  Date: March 31, 2025      By:      /s/ AnhCo Thieu Nguyen                                     
                                     AnhCo Thieu Nguyen